Cosela® (trilaciclib)
for Lung Cancer

Cosela (trilaciclib) is used to help prevent bone marrow suppression in adults receiving chemotherapy for extensive-stage small cell lung cancer (ES-SCLC). Given before chemotherapy, it reduces myelosuppression caused by drugs like platinum/etoposide or topotecan. Cosela helps maintain healthy levels of red and white blood cells and platelets, lowering the need for transfusions and supporting the immune system.

Heart
Other top medicines used to treat Lung Cancer